Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), sold 184,000 shares at $6.25 ($1.1M) on 2018-09-06, disclosed to the SEC on 2018-09-10.
Open-market sale of $1.1M TXMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.25 | 92,000 | $575K | 50.1% |
| 2 | $6.22 | 92,000 | $572K | 49.9% |
| Total | $6.24 avg | 184,000 | $1.1M | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |